Bupivacaine Hydrochloride With Dextrose has 23 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Acetaminophen, Acetazolamide, Chloroquine. Patients taking Bupivacaine Hydrochloride With Dextrose should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 23
- Moderate
- 23
Moderate (23)
- Bupivacaine Hydrochloride With Dextrose + Acetaminophen— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Acetazolamide— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Chloroquine— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Cyclophosphamide— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Dapsone— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Flutamide— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Hydroxyurea— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Ifosfamide— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Local Anesthetics (Articaine, Benzocaine, Lidocaine, Mepivacaine, Prilocaine, Procaine, Ropivacaine, Tetracaine)— Toxic effects of local anesthetics are additive. Monitor for neurologic and cardiovascular effects related to local anes…
- Bupivacaine Hydrochloride With Dextrose + Metoclopramide— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Nitric Oxide— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Nitrofurantoin— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Nitroglycerin— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Nitroprusside— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Nitrous Oxide— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Para-Aminosalicylic Acid— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Phenobarbital— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Phenytoin— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Primaquine— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Quinine— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Rasburicase— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Sulfasalazine— Increased risk of developing methemoglobinemia when concurrently exposed.
- Bupivacaine Hydrochloride With Dextrose + Valproate Sodium— Increased risk of developing methemoglobinemia when concurrently exposed.